This is an example page. It’s different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this:

Hi there! I’m a bike messenger by day, aspiring actor by night, and this is my website. I live in Los Angeles, have a great dog named Jack, and I like piña coladas. (And gettin’ caught in the rain.)

…or something like this:

The XYZ Doohickey Company was founded in 1971, and has been providing quality doohickeys to the public ever since. Located in Gotham City, XYZ employs over 2,000 people and does all kinds of awesome things for the Gotham community.

As a new WordPress user, you should go to your dashboard to delete this page and create new pages for your content. Have fun!

May 15, 2020

NOUL INHIBITOR JAK ACTIONEAZA EFICIENT IN TRATAMENTUL COLITEI ULCERATIVE

Un inhibitor selectiv al Janus kinazei intestinale numit TD-1473 s-a aratat a fi eficient in tratarea colitei ulcerative....
May 15, 2020

ETROLIZUMAB CA TRATAMENT DE INDUCTIE IN BOALA CROHN MODERAT – SEVERA : REZULTATE DIN STUDIUL BERGAMOT – cohorta 1

Etrolizumab (ETRO), un anticorp monoclonal anti-β7, a fost folosit ca terapie de inductie la pacientii cu b. Crohn...
May 11, 2020

COVID-19 in bolile inflamatorii intestinale

SECURE-IBD este o baza de date internationala in care sunt inregistrati pacientii cu boala inflamatorie intestinala (BII) infectati cu noul coronavirus, ...
February 2, 2020

Supozitoarele cu tacrolimus vs cele cu Beclometazona in proctita ulcerativa

S-a realizat un studiu dublu-orb randomizat pentru a compara eficienta Tacrolimusului in comparatie ...
February 2, 2020

Beneficiile pe termen lung ale inhibitorilor TNF in boala Crohn masurate endoscopic

Studiu prospectiv efectuat intr-un singur centru, se includ pacienti cu boala Crohn activa ce necesita tratament cu agenti anti TNF...
February 2, 2020

Bolile inflamatorii intestinale si afectarea osoasa

Dintre pacientii ce sufera de o boala inflamatorie intestinala, mai mult de 50 % prezinta si cel putin o manifestare extraintestinala. Printre aceste manifestari, cele ce afecteaza sistemul osos sunt cele mai intalnite...
November 18, 2019

Tratamentul local cu celule stem in boala Crohn fistulizanta, perianal

S-a efectuat o analiza pentru a determina asocierea intre utilizarea 5 ASA si riscul de CCR la pacientii cu boli inflamatorii intestinale. Au fost incluse 31 studii observationale
November 18, 2019

Rezectia ileo-cecala laparoscopica versus infliximab

S-a efectuat o analiza pentru a determina asocierea intre utilizarea 5 ASA si riscul de CCR la pacientii cu boli inflamatorii intestinale. Au fost incluse 31 studii observationale
November 17, 2019

5-AMINOSALICILATI si riscul de CCR la pacientii cu BII

S-a efectuat o analiza pentru a determina asocierea intre utilizarea 5 ASA si riscul de CCR la pacientii cu boli inflamatorii intestinale. Au fost incluse 31 studii observationale
Buy now